Laryngeal papillomatosis future or investigational therapies

Revision as of 18:08, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Laryngeal papillomatosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Laryngeal papillomatosis from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal papillomatosis future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal papillomatosis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal papillomatosis future or investigational therapies

CDC on Laryngeal papillomatosis future or investigational therapies

Laryngeal papillomatosis future or investigational therapies in the news

Blogs on Laryngeal papillomatosis future or investigational therapies

Directions to Hospitals Treating Laryngeal papillomatosis

Risk calculators and risk factors for Laryngeal papillomatosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Scientists and clinicians are working to discover more about laryngeal papillomatosis. While HPV 6 and HPV 11 are known causes, millions of people are exposed to these two viruses without developing the disease. It is not known why some people are more at risk than others or why some cases are much more serious than others.

Researchers funded by the National Institute on Deafness and Other Communication Disorders (NIDCD) are exploring how our genes and immune system may contribute to our risk for contracting the disease as well as the severity of its symptoms. Researchers are also studying other possible therapies for laryngeal papillomatosis. In one clinical trial, researchers are investigating whether a common anti-inflammatory drug can inhibit an enzyme that promotes tumor growth in laryngeal papillomatosis, thus reducing the recurrence of tumors in children and adults with laryngeal papillomatosis. Researchers are also investigating the effectiveness of a pulsed dye laser, a laser that delivers short intense pulses of light, to determine if it is more effective at preserving the surrounding tissue while removing tumors from vocal folds. In one NIDCD- sponsored clinical investigation, researchers are studying whether a certain dietary supplement can work with the pulsed dye laser to decrease the rate of recurrence of tumors in children with laryngeal papillomatosis. To read about these and other clinical trials, go to Pulsed Dye Laser for Juvenile Onset Recurrent Respiratory Papillomatosis.

References

Template:WH Template:WS